Your browser doesn't support javascript.
loading
Pharmacogenomic and pharmacoproteomic studies of cetuximab in metastatic colorectal cancer: biomarker analysis of a phase I dose-escalation study.
Tabernero, Josep; Cervantes, Andres; Rivera, Fernando; Martinelli, Erika; Rojo, Federico; von Heydebreck, Anja; Macarulla, Teresa; Rodriguez-Braun, Edith; Eugenia Vega-Villegas, Maria; Senger, Stefanie; Ramos, Francisco Javier; Roselló, Susana; Celik, Ilhan; Stroh, Christopher; Baselga, José; Ciardiello, Fortunato.
Affiliation
  • Tabernero J; Medical Oncology Department, Vall d'Hebron University Hospital, P. Vall d'Hebron, 119-129, 08035 Barcelona, Spain. jtabernero@vhebron.net
J Clin Oncol ; 28(7): 1181-9, 2010 Mar 01.
Article in En | MEDLINE | ID: mdl-20100964
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Proteomics / ErbB Receptors / Antibodies, Monoclonal / Neoplasm Proteins Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Clin Oncol Year: 2010 Document type: Article Affiliation country: España
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Proteomics / ErbB Receptors / Antibodies, Monoclonal / Neoplasm Proteins Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Clin Oncol Year: 2010 Document type: Article Affiliation country: España